These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 16716446)
1. Mismatch repair system (MMR) status correlates with response and survival in non-small cell lung cancer (NSCLC) patients. Scartozzi M; Franciosi V; Campanini N; Benedetti G; Barbieri F; Rossi G; Berardi R; Camisa R; Silva RR; Santinelli A; Ardizzoni A; Crinò L; Rindi G; Cascinu S Lung Cancer; 2006 Jul; 53(1):103-9. PubMed ID: 16716446 [TBL] [Abstract][Full Text] [Related]
2. Human colon cancer cells surviving high doses of cisplatin or oxaliplatin in vitro are not defective in DNA mismatch repair proteins. Sergent C; Franco N; Chapusot C; Lizard-Nacol S; Isambert N; Correia M; Chauffert B Cancer Chemother Pharmacol; 2002 Jun; 49(6):445-52. PubMed ID: 12107548 [TBL] [Abstract][Full Text] [Related]
3. hMSH2 and hMLH1 gene expression patterns differ between lung adenocarcinoma and squamous cell carcinoma: correlation with patient survival and response to adjuvant chemotherapy treatment. Vageli DP; Zaravinos A; Daniil Z; Dahabreh J; Doukas SG; Spandidos DA; Gourgoulianis KI; Koukoulis GK Int J Biol Markers; 2013 Jan; 27(4):e400-4. PubMed ID: 22865300 [TBL] [Abstract][Full Text] [Related]
4. Significance of mismatch repair protein expression in the chemotherapeutic response of sporadic invasive ductal carcinoma of the breast. Son BH; Ahn SH; Ko CD; Ka IW; Gong GY; Kim JC Breast J; 2004; 10(1):20-6. PubMed ID: 14717755 [TBL] [Abstract][Full Text] [Related]
5. Histopathology and mismatch repair status of 458 consecutive colorectal carcinomas. Wright CL; Stewart ID Am J Surg Pathol; 2003 Nov; 27(11):1393-406. PubMed ID: 14576472 [TBL] [Abstract][Full Text] [Related]
6. Analysis of MLH1 and MSH2 expression in ovarian cancer before and after platinum drug-based chemotherapy. Samimi G; Fink D; Varki NM; Husain A; Hoskins WJ; Alberts DS; Howell SB Clin Cancer Res; 2000 Apr; 6(4):1415-21. PubMed ID: 10778972 [TBL] [Abstract][Full Text] [Related]
8. Expression of the mismatch repair gene hMLH1 is enhanced in non-small cell lung cancer with EGFR mutations. Li M; Zhang Q; Liu L; Lu W; Wei H; Li RW; Lu S PLoS One; 2013; 8(10):e78500. PubMed ID: 24205245 [TBL] [Abstract][Full Text] [Related]
9. Loss of expression of DNA repair enzymes MGMT, hMLH1, and hMSH2 during tumor progression in gastric cancer. Kitajima Y; Miyazaki K; Matsukura S; Tanaka M; Sekiguchi M Gastric Cancer; 2003; 6(2):86-95. PubMed ID: 12861399 [TBL] [Abstract][Full Text] [Related]
10. hMLH1 and hMSH2 expression in human hepatocellular carcinoma. Wang L; Bani-Hani A; Montoya DP; Roche PC; Thibodeau SN; Burgart LJ; Roberts LR Int J Oncol; 2001 Sep; 19(3):567-70. PubMed ID: 11494037 [TBL] [Abstract][Full Text] [Related]
11. Expression of mismatch repair proteins, hMLH1/hMSH2, in non-small cell lung cancer tissues and its clinical significance. Kouso H; Yoshino I; Miura N; Takenaka T; Ohba T; Yohena T; Osoegawa A; Shoji F; Maehara Y J Surg Oncol; 2008 Oct; 98(5):377-83. PubMed ID: 18646042 [TBL] [Abstract][Full Text] [Related]
12. DNA mismatch repair genes hMLH1, hMSH2, and hMSH6 are not inactivated in bronchioloalveolar carcinomas of the lung. Aubry MC; Halling KC; Myers JL; Tazelaar HD; Yang P; Thibodeau SN Cancer; 2001 Dec; 92(11):2898-901. PubMed ID: 11753964 [TBL] [Abstract][Full Text] [Related]
13. hMLH1 and hMSH2 expression correlates with allelic imbalance on chromosome 3p in non-small cell lung carcinomas. Xinarianos G; Liloglou T; Prime W; Maloney P; Callaghan J; Fielding P; Gosney JR; Field JK Cancer Res; 2000 Aug; 60(15):4216-21. PubMed ID: 10945633 [TBL] [Abstract][Full Text] [Related]
14. The frequency of hereditary defective mismatch repair in a prospective series of unselected colorectal carcinomas. Cunningham JM; Kim CY; Christensen ER; Tester DJ; Parc Y; Burgart LJ; Halling KC; McDonnell SK; Schaid DJ; Walsh Vockley C; Kubly V; Nelson H; Michels VV; Thibodeau SN Am J Hum Genet; 2001 Oct; 69(4):780-90. PubMed ID: 11524701 [TBL] [Abstract][Full Text] [Related]
15. Loss of hMLH1 expression correlates with improved survival in stage III-IV ovarian cancer patients. Scartozzi M; De Nictolis M; Galizia E; Carassai P; Bianchi F; Berardi R; Gesuita R; Piga A; Cellerino R; Porfiri E Eur J Cancer; 2003 May; 39(8):1144-9. PubMed ID: 12736115 [TBL] [Abstract][Full Text] [Related]
16. Hsp27, Hsp70 and mismatch repair proteins hMLH1 and hMSH2 expression in peripheral blood lymphocytes from healthy subjects and cancer patients. Nadin SB; Vargas-Roig LM; Drago G; Ibarra J; Ciocca DR Cancer Lett; 2007 Jul; 252(1):131-46. PubMed ID: 17276589 [TBL] [Abstract][Full Text] [Related]
17. Transient mismatch repair gene transfection for functional analysis of genetic hMLH1 and hMSH2 variants. Brieger A; Trojan J; Raedle J; Plotz G; Zeuzem S Gut; 2002 Nov; 51(5):677-84. PubMed ID: 12377806 [TBL] [Abstract][Full Text] [Related]
18. Inactivation of hMLH1 and hMSH2 by promoter methylation in primary non-small cell lung tumors and matched sputum samples. Wang YC; Lu YP; Tseng RC; Lin RK; Chang JW; Chen JT; Shih CM; Chen CY J Clin Invest; 2003 Mar; 111(6):887-95. PubMed ID: 12639995 [TBL] [Abstract][Full Text] [Related]